{"id":"NCT00142584","sponsor":"Mylan Bertek Pharmaceuticals","briefTitle":"Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension","officialTitle":"An Open-label, Randomized Study Evaluating the Long-term Effects of Metoprolol (MET) Versus Nebivolol (NEB) as Monotherapy or in Combination With Amlodipine or Hydrochlorothiazide for the Treatment of Patients With Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08","primaryCompletion":"2008-03","completion":"2008-03","firstPosted":"2005-09-02","resultsPosted":"2022-03-15","lastUpdate":"2022-03-15"},"enrollment":336,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Nebivolol (NEB)","otherNames":[]},{"type":"DRUG","name":"Metoprolol (MET)","otherNames":[]}],"arms":[{"label":"1-NEB","type":"EXPERIMENTAL"},{"label":"2-MET","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate long-term safety,tolerability and blood pressure effects of metoprolol versus nebivolol in patients with hypertension. These drugs may be given alone or in combination with other drugs that are commonly used in the treatment of hypertension","primaryOutcome":{"measure":"Change in Average Sitting Diastolic Blood Pressure (DBP) Taken at Trough at the End of Treatment Compared to Baseline","timeFrame":"Through study duration (approximately 18 months)","effectByArm":[{"arm":"1-NEB","deltaMin":-14,"sd":9.8},{"arm":"2-MET","deltaMin":-10.9,"sd":8.73}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":252},"commonTop":["HEADACHE","Arthralgia","Back pain","Nasopharyngitis","Upper respiratory tract infection"]}}